Related
[News article] Vapor from e-cigarettes triggers changes to cells in lab study
From the 27 January 2015 article at Covering Health – Monitoring the Pulse of Health Journalism by Mary Otto
Photo: Jonny Williams via Flickr
This image is released under Creative Commons. If used, please attribute to http://www.ecigclick.co.ukElectronic cigarettes, or e-cigarettes are growing in popularity among American adults, and while some states restrict their use by minors, nearly 1.8 million American middle and high school students reported using them one recent year, a federal study found.
…
Manufacturers promote e-cigarettes as safer alternatives to conventional cigarettes and as tools for smoking cessation. Yet researchers point out that there is a dearth of scientific evidence regarding the effects of e-cigarette vapors on the lungs.
A laboratory study published in September suggests vapor from e-cigarettes may cause damage and raise the risk for respiratory infections among young people. In the lab, the vapor triggered a strong immune response in the epithelial cells of tissue samples donated by deceased children and the exposed cells appeared to be more vulnerable to infection by cold-causing rhinovirus, according to the research article, published in PLOS One. According to the study, even nicotine-free vapor increased the risk of infection.
HealthDay News reporter Dennis Thompson, who has been following the research on e-cigarette safety, took a look at the findings this month in a story posted on WebMD.
“Epithelial cells are the first line of defense in our airways,” the study’s lead author, Qun Wu, a lung disease researcher at National Jewish Health in Denver explains in Thompson’s article.
“They protect our bodies from anything dangerous we might inhale. Even without nicotine, this liquid can hurt your epithelial defense system and you will be more likely to get sick.”
Wu and his team placed the human cells in a sterile container in one end of a machine with an e-cigarette at the other end, Thompson notes. “The vapor spurred the release of IL-6, a signalling protein that promotes inflammation and an immune system response. This occurred whether or not the vapor contained nicotine, although nicotine appeared to slightly enhance the release of IL-6, the researchers said.”
An industry group representing e-cigarette manufacturers is stressing the limits of the study, pointing out that the tests involved cells in a lab, not actual e-cigarette users.
“Many in public health agree that the risks of vaping must always be considered in the context of the risks of cigarette smoking and traditional stop-smoking therapies,” Gregory Conley, president of the American Vaping Association observes in Thompson’s article.
….
Related articles
What Should You Know About E-Cigarettes?
On a personal note, my husband is very sensitive to e-cigarette vapors.
He finds he has to leave any room where they are being “smoked”.
From the 23 October 2013 ScienceDaily article
E-cigarettes are becoming increasingly popular and widely available as the use of regular cigarettes drops. Recently, the Centers for Disease Control and Prevention (CDC) reported that e-cigarette use by children doubled from 2011 and 2012. The health effects of e-cigarettes have not been effectively studied and the ingredients have little or no regulation. Mayo Clinic’s Nicotine Dependence Center experts are available to discuss what people should know before trying e-cigarettes
Electronic cigarettes, often called e-cigarettes, are battery-operated devices that provide inhaled doses of a vaporized solution of either propylene glycol or vegetable glycerin along with liquid nicotine. An atomizer heats the solution into a vapor that can be inhaled. The process, referred to as “vaping,” creates a vapor cloud that resembles cigarette smoke. Some liquids contain flavoring, making them more appealing to users.
“As of right now, there is no long-term safety data showing the impact of repeated inhalation of propylene glycol or vegetable glycerin on lung tissue,” cautions Jon Ebbert, M.D., associate director at Mayo Clinic’s Nicotine Dependence Center. “There is some short-term data suggesting that e-cigarettes may cause airway irritation, but until we have long-term safety data, we are not recommending e-cigarettes for use among cigarette smokers to help people stop smoking.”
So, what is known about electronic cigarettes?
*Manufacturers claim that electronic cigarettes are a safe alternative to conventional cigarettes.
*The Food and Drug Administration (FDA) has questioned the safety of these products.
*FDA analysis of two popular brands found variable amounts of nicotine and traces of toxic chemicals, including known cancer-causing substances (carcinogens).
*The FDA has issued a warning about potential health risks associated with electronic cigarettes, but is not yet regulating their use or standards of manufacture.
“It’s an amazing thing to watch a new product like that just kind of appear. There’s no quality control,” says Richard Hurt, M.D., director of Mayo Clinic’s Nicotine Dependence Center. “Many of them are manufactured in China under no control conditions, so the story is yet to be completely told.”
Related articles
- E-cigarette regulation debate heats up (wavy.com)
- Should e-cigs be treated like regular cigarettes? (utsandiego.com)
- Conn. Lawmaker To Propose Ban On E-Cigarettes In Public Places (newyork.cbslocal.com)
- Report Finds Too Many American Children Are Smoking Flavored Cigars (counselheal.com)
- Safer Cigarrettes (powerecigs.wordpress.com)
- Don’t smoke your e-cigarettes indoors, say London’s top restaurateurs (standard.co.uk)
- Cigarette alternatives may not be ‘safe’ tobacco (universityofcalifornia.edu)
- E-Cigarettes Now Being Used To Smoke Marijuana, Worrying Some Health Officials (medicaldaily.com)
- Council bureaucrats to ban “E-Cigarettes” in order to have a “clear policy” towards smoking. (visitscunthorpe.com)
Why Nicotine is a Gateway Drug – NIH Research Matters – National Institutes of Health (NIH)
Why Nicotine is a Gateway Drug – NIH Research Matters – National Institutes of Health (NIH)
From the 21 November article
A new study in mice shows how tobacco products could act as gateway drugs, opening the door to use of illicit drugs. Nicotine, the researchers found, makes the brain more susceptible to cocaine addiction. The finding suggests that lowering smoking rates in young people might help reduce cocaine abuse.
Scientists have long recognized that cigarettes and alcohol raise the risk for later use of illicit drugs like marijuana and cocaine. In a recent national survey, over 90% of adult cocaine users between the ages of 18 and 34 had smoked cigarettes before they began using cocaine. Researchers suspected that nicotine exposure might increase vulnerability to cocaine. However, no one had identified a biological mechanism. A team of scientists, led by Dr. Eric Kandel at Columbia University and supported by NIH’s National Institute on Drug Abuse (NIDA), set out to investigate.
In Science Translational Medicine on November 2, 2011, the scientists reported that mice given nicotine in their drinking water for 7 days showed increased activity in response to cocaine. The animals also had changes in a brain signaling process called long-term potentiation.
.
Related articles
- Nicotine Could Act As A Gateway Drug (medicalnewstoday.com)
- NIH study examines nicotine as a gateway drug (nih.gov)
- NIH study examines nicotine as a gateway drug (eurekalert.org)
- The real gateway drug: Nicotine (talesfromthelou.wordpress.com)
- Nicotine Causes Epigenetic Changes in Mice that Spur Cocaine Addiction | 80beats (blogs.discovermagazine.com)